Effect of diabetes on enzymes involved in rat hepatic corticosterone production
- 21 November 2010
- journal article
- Published by Wiley in Journal of Diabetes
- Vol. 2 (4) , 275-281
Abstract
Background: Numerous studies have explored the etiologic or permissive role of 11β‐hydroxysteroid dehydrogenase (11β‐HSD1) in obesity and Type 2 diabetes, biochemical conditions often with concurrent hyperinsulinism. In contrast, there are limited data on the effect of insulin deficiency (i.e. Type 1 diabetes) on 11β‐HSD1 or endoplasmic reticulum enzymes that generate the reduced pyridine cofactor NADPH. Thus, the aim of the present study was to examine the effect of insulin‐deficient, streptozotozin diabetes on key microsomal enzymes involved in rat hepatic corticosterone production.Methods: After rats had been rendered diabetic with streptozotocin and some had been treated with insulin (2–6 units, s.c., long‐acting insulin once daily) for 7 days, hepatic microsomes were isolated. Serum corticosterone and fructosamine were obtained premortem. Intact microsomes were incubated in vitro and 11β‐HSD1, hexose‐6‐phosphate dehydrogenase (H6PDH), and isocitrate dehydrogenase (IDH) measured.Results: Although diabetes markedly altered body weight gain and serum protein glycosylation (assessed by fructosamine), there was no significant change in hepatic 11β‐HSD1 reductase activity, with or without insulin treatment. However, serum corticosterone levels were significantly correlated with 11β‐HSD1 reductase activity when all groups were analyzed together (P < 0.05). Untreated diabetes modified (P < 0.01) two hepatic microsomal NADPH‐generating enzymes, namely H6PDH and IDH, resulting in a 37% decrease and 14% increase in enzyme levels, respectively.Conclusions: Consistent with most in vivo studies, chronic insulin deficiency with attendant hyperglycemia does not significantly modify hepatic 11β‐HSD1 reductase activity, but does alter the activity of two microsomal enzymes coupled with pyridine cofactors.Keywords
This publication has 31 references indexed in Scilit:
- Contrasting Influence of NADPH and a NADPH-Regenerating System on the Metabolism of Carbonyl-Containing Compounds in Hepatic MicrosomesDrug Metabolism and Disposition, 2009
- Protective effects of mildronate in an experimental model of type 2 diabetes in Goto‐Kakizaki ratsBritish Journal of Pharmacology, 2009
- Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulumJournal of Molecular Endocrinology, 2008
- Insulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1Endocrinology, 2008
- Modification of microsomal 11β-HSD1 activity by cytosolic compounds: Glutathione and hexose phosphoestersThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) geneMolecular and Cellular Endocrinology, 2008
- Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase is based on a common pyridine nucleotide pool in the lumen of the endoplasmic reticulumMolecular and Cellular Endocrinology, 2006
- Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?Molecular and Cellular Endocrinology, 2006
- Effect of growth hormone, insulin and dexamethasone on 11 β -hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytesLife Sciences, 1996
- Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus.BMJ, 1985